Workflow
A股、港股、A50,全线翻红!
Zheng Quan Shi Bao Wang·2025-06-23 08:09

Market Performance - The Hang Seng Technology Index saw an increase of up to 1% in the afternoon, with semiconductor and gold jewelry sectors performing strongly, particularly Hua Hong Semiconductor and SMIC, which rose nearly 5% [1] - On June 23, all three major A-share indices closed higher, with the Shanghai Composite Index up 0.65%, the Shenzhen Component Index up 0.43%, and the ChiNext Index up 0.39%. The North Star 50 index rose over 1.5%, with Long Rainbow Energy and Air China Ocean leading the gains [2] - The FTSE China A50 index futures also turned positive [3] AI and AR Glasses Sector - The AI glasses concept saw a significant rise in the afternoon, with Dayu Optoelectronics hitting the daily limit, and companies like Huazang Optoelectronics, Mingyue Lens, Weida Optoelectronics, Guoxing Optoelectronics, and Zhongjing Electronics also experiencing gains [5] - Institutions predict a positive outlook for AI/AR glasses in the second half of the year, with the upcoming release of Rokid Glasses and the Meta Connect 2025 event focusing on advancements in AI glasses and related technologies [7] - The smart glasses market is heating up due to the integration of AI models and augmented reality technology, leading to increased sales and a boost in the entire industry chain [7] Stablecoin and Cross-Border Payment Sector - Stablecoin-related stocks surged in the afternoon, with Sifang Precision hitting the daily limit and companies like Ubo Technology and Hailian Jinhui also seeing significant gains [7] - The cross-border payment concept stocks expanded their gains, with Lakala and Advanced Communication rising over 10%, following the launch of the Cross-Border Payment System, which allows real-time remittances between mainland China and Hong Kong [8] Innovative Drug and Medical Device Sector - The innovative drug sector saw a rebound, with companies like Saily Medical hitting the daily limit and Microchip Bio rising nearly 15%, following new regulatory measures to expedite clinical trial approvals [8][10] - The medical device sector continued to rise, with Haobo Bio hitting the daily limit and companies like Kangwei Century and Kangzhong Medical also experiencing gains, supported by new measures to promote innovation in high-end medical devices [10]